Banner - NPPA Connect

Opinion|Videos|December 5, 2024

The JAK Revolution in Vitiligo

Author(s)James Song, MD, FAAD

James Song, MD, discusses how Janus kinase (JAK) inhibitors represent a breakthrough in vitiligo treatment by effectively targeting the immune pathways responsible for depigmentation, offering patients a powerful new therapeutic option with promising repigmentation results.

Episodes in this series

1 KOL is featured in this series.

EP. 1 Collaborating With Communities to Manage Pediatric Vitiligo

1 KOL is featured in this series.

EP. 2 Anticipating Advances for Pediatric Vitiligo

1 KOL is featured in this series.

EP. 3 Telehealth and Research Strides for Young Patients

1 KOL is featured in this series.

EP. 4 Managing Expectations and Holistically Treating Patients With Vitiligo

1 KOL is featured in this series.

EP. 5 Vitiligo Repigmentation Challenges and Evaluating Treatment Success

1 KOL is featured in this series.

EP. 6 Clinical Presentation

1 KOL is featured in this series.

EP. 7 Promising and Emerging Therapies in the Vitiligo Landscape

1 KOL is featured in this series.

EP. 8 The JAK Revolution in Vitiligo

1 KOL is featured in this series.

EP. 9 Balancing Safety and Efficacy With Key Data

1 KOL is featured in this series.

EP. 10 Vitiligo Treatment Patterns and Pearls for Adults Versus Pediatric Patients

1 KOL is featured in this series.

EP. 11 Tailoring Treatments and Counseling Patients With Pediatric Vitiligo

1 KOL is featured in this series.

EP. 12 Safety, Efficacy, and Treatment Adherence in Young Patients With Vitiligo

EP. 13 Treatment Insights and Evolving Care Options in Vitiligo

EP. 13 Treatment Insights and Evolving Care Options in Vitiligo

1 KOL is featured in this series.

EP. 14 Key Differences in Onset, Progression, Diagnosis, and Treatment of Pediatric Vitiligo

1 KOL is featured in this series.

EP. 15 Addressing Psychological and Social Impacts of Pediatric Vitiligo

1 KOL is featured in this series.

EP. 16 Promoting Open and Positive Dialogue With Families of Patients With Pediatric Vitiligo

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.

Related Content

1 expert is featured in this series

Addressing Steroid Fear with Non-Steroidal Treatment Options in Psoriasis

ByTina Bhutani-Jacques, MD

September 4th 2026

1 expert is featured in this series

Setting Realistic Treatment Goals for Localized Plaque Psoriasis

ByTina Bhutani-Jacques, MD

September 4th 2026

1 expert is featured in this series

Skin Clearance and PsA Prevention with Biologics in Psoriasis

ByBruce Strober, MD, PhD

September 1st 2026

1 expert is featured in this series

Case 3: Redefining How We Classify Psoriasis Severity

ByTina Bhutani-Jacques, MD

August 28th 2026

1 expert is featured in this series

Why One Foam Works for Scalp and Body Psoriasis

ByTina Bhutani-Jacques, MD

August 28th 2026

Latest CME

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Trending on Dermatology Times

AbbVie Completes $10.9 Billion Apogee Acquisition, Adds Zumilokibart to AD Pipeline

Uncovering the Autoimmune Links & Systemic Impact of Chronic Spontaneous Urticaria

10 Skin Cancer Exam Tips

Dermatology Times Conferences & Meetings Calendar: September 2026

Early Recognition and Psychosocial Impact in Male Pattern Hair Loss